James F. Abell
Consultor / Asesor en Abingworth LLP .
Origen de la red de primer grado James F. Abell.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022.
33
| Subsidiary | Investment Managers | 33 |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom.
13
| Private Company | Investment Managers | 13 |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom.
3
| Subsidiary | Biotechnology | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a James F. Abell a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Cambridge | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree | |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Adaptate Biotherapeutics Ltd.
 Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
Abingworth Bioventures GP Ltd.
 Abingworth Bioventures GP Ltd. Other TransportationTransportation Abingworth Bioventures GP Ltd. provides marine cargo handling facilities. The company was founded on March 29, 2012 and is headquartered in London, the United Kingdom. | Other Transportation | Director/Board Member Director/Board Member Director/Board Member | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor Private Equity Investor Chief Executive Officer | |
Gynesonics, Inc.
 Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Lightspeed Management Co LLC
 Lightspeed Management Co LLC Investment ManagersFinance Lightspeed Management Co. LLC (Lightspeed Venture Partners) is a venture capital firm founded in 1971. The firm is headquartered in Menlo Park, California. It was formerly known as Weiss, Peck & Greer Venture Partners. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Sussex | College/University | Doctorate Degree Graduate Degree | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree Doctorate Degree | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree Graduate Degree | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AVEDRO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| SIENTRA, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Inmediata Health Group
 Inmediata Health Group Electronic Production EquipmentElectronic Technology Inmediata Health Group offers electronic solutions for enhancing the efficiency and the quality of health and dental care. It solutions include core compliance support, multi-payer reimbursement portal platform, payment adoption initiative and claims. The company was founded by Severiano Lopez in 2006 and is headquartered in Charlotte, NC. | Electronic Production Equipment | Director/Board Member Director/Board Member | |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Packaged Software | Director/Board Member Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Undergraduate Degree | |
TeneoBio, Inc.
 TeneoBio, Inc. Miscellaneous Commercial ServicesCommercial Services TeneoBio, Inc. operates as a biotechnology company that develops biologics, human heavy chain antibodies, as therapeutics against cancer, autoimmunity, and infectious diseases. Its products provides treatment of multiple myeloma, prostate cancer, immune disorders, and AIDS. The company was founded by Roland Buelow, on August 9, 2009 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Novartis Inflammasome Research, Inc.
 Novartis Inflammasome Research, Inc. Pharmaceuticals: MajorHealth Technology Novartis Inflammasome Research, Inc. operates as a biopharmaceutical company, which engages in the development of a suite of NOD-, LRR- and pyrin domain-containing 3 (NLRP3) antagonists for the treatment of inflammatory diseases. It also develops chemically distinct systemic, gut-directed, and central nervous system (CNS)-penetrant drug candidates to address a breadth of indications triggered by NLRP3, including metabolic, fibrotic, autoimmune, autoinflammatory, and neurological diseases. The company was founded by Eicke Latz and Luigi Franchi in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| PERSONALIS, INC. | Medical/Nursing Services | Director/Board Member Chairman | |
Launch Therapeutics, Inc.
 Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Direct Conversion AB
 Direct Conversion AB Medical SpecialtiesHealth Technology Direct Conversion AB manufactures and supplies X-Ray detectors such as cadmium telluride (CdTe) detectors. Its products include XC-THOR, XC-HYDRA, XC-TDI, XC-ACTAEON, SNAP 225, SNAP 150 and SNAP 100X2. The firm’s products are used in the dental, medical, welding, industrial, food and security industries. The company was founded in 1997 and is headquartered in Danderyd, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member | |
| EPIGENOMICS AG | Medical Specialties | Director/Board Member Director/Board Member | |
| King's College London | College/University | Undergraduate Degree Masters Business Admin | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Venatorx Pharmaceuticals, Inc.
 Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 25 |
| Reino Unido | 18 |
| Suecia | 3 |
| Suiza | 2 |
| Francia | 2 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 6 |
| Electronic Technology | 3 |
Operativa
| Director/Board Member | 251 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 41 |
| Private Equity Investor | 39 |
| Chairman | 30 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Timothy Haines | 36 |
| Kurt von Emster | 34 |
| Shelley Chu | 31 |
| Michael Bigham | 27 |
| Jonathan MacQuitty | 27 |
| John Berriman | 24 |
| Stephen William Bunting | 22 |
| Bali Muralidhar | 20 |
| Melanie Lee | 19 |
| Genghis Lloyd-Harris | 19 |
| Joseph Anderson | 19 |
| Kenneth H. Haas | 17 |
| Vincent J. Miles | 17 |
| David J. Mayer | 15 |
| Andrew Sinclair | 14 |
- Bolsa de valores
- Insiders
- James F. Abell
- Conexiones Empresas
